Terns Pharmaceuticals Inc (TERN) Stock Price, Quote & News

Company Profile

Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology and obesity. The company develops TERN-701, an allosteric BCR-ABL tyrosine kinase inhibitor (TKI) that is in Phase 1 clinical trial for chronic myeloid leukemia (CML), a form of cancer that starts in bone marrow. It also develops TERN-501, a thyroid hormone receptor beta agonist with enhanced liver distribution and metabolic stability that is in Phase...

Industry: Biotechnology

Sector: Healthcare

Phone: 650 525 5535

Fax: 650 275 4254

Website: www.ternspharma.com

Address:

1065 East Hillsdale Boulevard, Suite 100, Foster City, United States

TraderLawJCF Jan. 7 at 9:17 PM

$TERN These moves are so funny…MM are such scumbags but 98% held by institutions!

0 · Reply

RMN1 Jan. 7 at 2:33 PM

$TERN - What do you think? SHORT -or- PUT ??

2 · Reply

RMN1 Jan. 6 at 4:51 PM

$TERN

0 · Reply

StardustTrader Jan. 6 at 4:10 PM

$TERN

1 · Reply

MoneyGroupLLC Jan. 6 at 3:30 PM

Enter: $TERN Calls Strike Price: $40 Expiry Date: FEB 20 2026 Buy in Price: $4.10 - $4.30 Sell Price: $8.73 Profit : +113% (Turn every $1 into $2.13) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us/

0 · Reply

JoeDirty Jan. 6 at 2:35 PM

$ALT Is $ALT more valuable than $VKTX now? The market will tell us soon as it did with $TERN

0 · Reply

RMN1 Jan. 6 at 2:33 PM

$TERN .. SHORT / PUT ???

0 · Reply

BIOTECH_GURU Jan. 6 at 2:18 PM

$TERN $ALMS $PRME $ALT $CAPR 2 month check up. How am I doing?

7 · Reply

BIOTECH_GURU Jan. 5 at 11:48 PM

$ALMS who got shook out this morning? Similar thing happened to $TERN before the 5x run. A bunch of fake bulls got run out bya selloff. Good luck to all who held.

0 · Reply

IsabellaDC Jan. 5 at 6:50 PM

$TERN Can / will it pivot from the pivot? Patience and planning.

0 · Reply

Terns Pharmaceuticals to Highlight 2026 Priorities and Program Milestones at the 44th Annual J.P. Morgan Healthcare Conference

Jan 2, 2026, 4:05 PM EST - 5 days ago

Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)

Dec 15, 2025, 6:31 PM EST - 22 days ago

Terns CEO Amy Burroughs talks cancer drug trial win

Dec 11, 2025, 4:05 PM EST - 27 days ago

Terns Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares

Dec 9, 2025, 11:30 PM EST - 4 weeks ago

Terns Announces Pricing of Upsized $650 Million Public Offering

Dec 9, 2025, 3:31 PM EST - 4 weeks ago

Cancer Study Buoys These Small Biotechs

ACLX LEGN

Dec 9, 2025, 2:34 PM EST - 4 weeks ago

Terns Pharmaceuticals: CML Data Blows Wall Street Away - Again

Dec 9, 2025, 6:12 AM EST - 4 weeks ago

Terns Announces Proposed Public Offering

Dec 8, 2025, 11:27 PM EST - 4 weeks ago

Terns Pharmaceuticals, Inc. (TERN) Discusses Efficacy and Safety Data Update for TERN-701 in Chronic Myeloid Leukemia Transcript

$Terns Highlights Additional Positive Phase 1 Clinical Data Supporting TERN-701's Best-in-Disease Potential in Relapsed/Refractory CML at the 67th ASH Annual Meeting$

Dec 8, 2025, 2:45 PM EST - 4 weeks ago

Terns Highlights Additional Positive Phase 1 Clinical Data Supporting TERN-701's Best-in-Disease Potential in Relapsed/Refractory CML at the 67th ASH Annual Meeting

Nov 14, 2025, 4:05 PM EST - 7 weeks ago

Terns Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference in London

Nov 10, 2025, 4:05 PM EST - 2 months ago

Terns Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Corporate Updates

Nov 3, 2025, 1:05 PM EST - 2 months ago

Terns Pharmaceuticals' Leukemia Drug Seen As Potential Disruptor In CML Treatment Landscape, Analyst Upgrades

$Terns Announces Abstract with Positive Clinical Data for TERN-701 in Relapsed/Refractory CML Selected for Oral Presentation at 67th ASH Annual Meeting$

Nov 3, 2025, 9:05 AM EST - 2 months ago

Terns Announces Abstract with Positive Clinical Data for TERN-701 in Relapsed/Refractory CML Selected for Oral Presentation at 67th ASH Annual Meeting

Oct 22, 2025, 2:43 PM EDT - 2 months ago

Why Is Terns Pharmaceuticals Stock Trading Lower After Obesity Trial Data?

Oct 21, 2025, 4:56 PM EDT - 2 months ago

Terns Pharma ends obesity drug program after mid-stage trial data

Oct 21, 2025, 4:05 PM EDT - 2 months ago

Terns Pharmaceuticals Reports Topline 12-week Data from its Phase 2 Trial Evaluating Oral GLP-1 Receptor Agonist TERN-601 in Obesity

Sep 10, 2025, 12:13 PM EDT - 4 months ago

Terns Pharmaceuticals, Inc. (TERN) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sep 3, 2025, 11:33 PM EDT - 4 months ago

Terns Pharmaceuticals, Inc. - TERN-701 Investor Educational Webinar Transcript

Aug 21, 2025, 4:05 PM EDT - 4 months ago

Terns Pharmaceuticals to Host an Educational Webinar on TERN-701 for Investors in Advance of Phase 1 Data Expected in Fourth Quarter 2025

Aug 5, 2025, 4:05 PM EDT - 5 months ago

Terns Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Corporate Updates

Jul 11, 2025, 11:27 AM EDT - 6 months ago

Terns Pharmaceuticals: A Risky Buy Ahead Of Q4 Obesity, Oncology Catalysts

Jun 23, 2025, 4:07 PM EDT - 7 months ago

Terns Pharmaceuticals Presents Positive Data from Phase 1 Study of TERN-601 Once-daily Oral GLP-1R Agonist for Treatment of Obesity at 85th Annual American Diabetes Association Scientific Sessions

May 29, 2025, 4:05 PM EDT - 7 months ago

Terns Pharmaceuticals to Participate in Upcoming June Investor Conferences

May 14, 2025, 9:30 AM EDT - 8 months ago

Terns Pharmaceuticals Selected for Oral Presentation at European Hematology Association Congress For Preclinical Data on Novel Allosteric BCR-ABL Inhibitor TERN-701

May 8, 2025, 4:05 PM EDT - 8 months ago

Terns Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Corporate Updates

Apr 30, 2025, 4:05 PM EDT - 9 months ago

Terns Pharmaceuticals to Participate in The Citizens Life Sciences Conference

Apr 2, 2025, 4:05 PM EDT - 10 months ago

Terns Pharmaceuticals Reports Inducement Grant to New Employees Under Nasdaq Listing Rule 5635(C)(4)

Mar 20, 2025, 4:05 PM EDT - 10 months ago

Terns Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates

Feb 26, 2025, 4:05 PM EST - 11 months ago

Terns Pharmaceuticals Reports Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(C)(4)

Feb 25, 2025, 8:05 AM EST - 11 months ago

Terns Pharmaceuticals Provides Program Updates and Announces Participation at TD Cowen 45th Annual Healthcare Conference

Feb 24, 2025, 4:05 PM EST - 11 months ago

Terns Pharmaceuticals Appoints Andrew Gengos as Chief Financial Officer

Feb 20, 2025, 4:05 PM EST - 11 months ago

Terns Pharmaceuticals Appoints Robert Azelby to Board of Directors

Feb 5, 2025, 4:05 PM EST - 1 year ago

Terns Pharmaceuticals to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference

Feb 3, 2025, 4:05 PM EST - 1 year ago

Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)

Jan 8, 2025, 4:05 PM EST - 1 year ago

Terns Pharmaceuticals to Present at 43rd Annual J.P. Morgan Healthcare Conference

Dec 4, 2024, 1:18 PM EST - 1 year ago

Terns's stock soars as analysts cheer leukemia data — and predict more gains

Dec 3, 2024, 8:01 AM EST - 1 year ago

Terns Pharma broadens beyond obesity drugs with upbeat data in leukemia trial

Nov 19, 2024, 7:52 AM EST - 1 year ago

Top 3 Health Care Stocks You'll Regret Missing In Q4

AMRN SLN

Nov 18, 2024, 4:05 PM EST - 1 year ago

Terns Pharmaceuticals Appoints Heather Turner, J.D., to Board of Directors

Nov 15, 2024, 11:19 AM EST - 1 year ago

RFK Jr. is not a fan of weight-loss drugs or vaccines. Stocks are tanking.

AMGN LLY NVO VKTX

Sep 25, 2024, 10:30 AM EDT - 1 year ago

Terns Pharmaceuticals: Obesity Advancement Continues With Other Q1 2025 Program Catalyst

Sep 13, 2024, 1:30 PM EDT - 1 year ago

Undercovered Stock Picks From September 6-12: Lithium, Uranium, Gold, & Plastic

ATLX BRZE DOCN EGO PL SLVM SMR

Sep 12, 2024, 7:00 PM EDT - 1 year ago

Terns Announces Closing of Public Offering of Shares of Common Stock and Pre-Funded Warrants, Including Full Exercise of Underwriters' Option to Purchase Additional Shares

Sep 10, 2024, 10:50 PM EDT - 1 year ago

Terns Announces Pricing of Upsized $150.15 Million Public Offering

Sep 10, 2024, 10:25 AM EDT - 1 year ago

Terns Pharmaceuticals: Weight Loss Drug TERN-601 Is Competitive

Sep 9, 2024, 9:58 AM EDT - 1 year ago

Terns Pharmaceuticals Stock Is Soaring on Good Data for Weight-Loss Pill

Sep 9, 2024, 9:12 AM EDT - 1 year ago

Top 2 Health Care Stocks That May Collapse This Quarter

IMVT

Sep 9, 2024, 7:48 AM EDT - 1 year ago

Terns Pharmaceuticals' stock soars 30% after biotech posts positive results in trial of weight-loss drug in pill form

Sep 9, 2024, 7:34 AM EDT - 1 year ago

Terns Pharmaceuticals' oral obesity drug cuts weight by 4.9% in early study

TraderLawJCF Jan. 7 at 9:17 PM

$TERN These moves are so funny…MM are such scumbags but 98% held by institutions!

0 · Reply

RMN1 Jan. 7 at 2:33 PM

$TERN - What do you think? SHORT -or- PUT ??

2 · Reply

RMN1 Jan. 6 at 4:51 PM

$TERN

0 · Reply

StardustTrader Jan. 6 at 4:10 PM

$TERN

1 · Reply

MoneyGroupLLC Jan. 6 at 3:30 PM

0 · Reply

JoeDirty Jan. 6 at 2:35 PM

$ALT Is $ALT more valuable than $VKTX now? The market will tell us soon as it did with $TERN

0 · Reply

RMN1 Jan. 6 at 2:33 PM

$TERN .. SHORT / PUT ???

0 · Reply

BIOTECH_GURU Jan. 6 at 2:18 PM

$TERN $ALMS $PRME $ALT $CAPR 2 month check up. How am I doing?

7 · Reply

BIOTECH_GURU Jan. 5 at 11:48 PM

$ALMS who got shook out this morning? Similar thing happened to $TERN before the 5x run. A bunch of fake bulls got run out bya selloff. Good luck to all who held.

0 · Reply

IsabellaDC Jan. 5 at 6:50 PM

$TERN Can / will it pivot from the pivot? Patience and planning.

0 · Reply

MoneyGroupLLC Jan. 4 at 9:28 PM

Enter: $TERN Calls Strike Price: $41 Expiry Date: FEB 20 2026 Buy in Price: $5.40 - $6.00 Sell Price: $10.31 Profit : +91% (Turn every $1 into $1.91) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us/

0 · Reply

MoneyGroupLLC Jan. 3 at 4:20 PM

Enter: $TERN Calls Strike Price: $41 Expiry Date: FEB 20 2026 Buy in Price: $5.40 - $6.00 Sell Price: $12.26 Profit : +127% (Turn every $1 into $2.27) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us/pricing

0 · Reply

RMN1 Jan. 2 at 5:34 PM

$TERN -- I hope you didn't miss my previous message regarding SHORT/PUTs.. Still not late!!

2 · Reply

RMN1 Jan. 2 at 4:29 PM

$TERN - SHORT / OUT ?? I have see many in biotech and medicine lot that follows this saying "A flame burns brightest just before it goes out" .. This is the time when big players plan and starts quitting with ..

1 · Reply

MoneyGroupLLC Jan. 2 at 3:32 PM

Enter: $TERN Calls Strike Price: $41 Expiry Date: FEB 20 2026 Buy in Price: $5.40 - $6.70 Sell Price: $9.83 Profit : +82% (Turn every $1 into $1.82) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us

0 · Reply

RMN1 Jan. 2 at 3:24 PM

$TERN

1 · Reply

MoneyGroupLLC Dec. 31 at 10:24 PM

Enter: $TERN Calls Strike Price: $41 Expiry Date: FEB 20 2026 Buy in Price: $5.40 - $7.00 Sell Price: $9.23 Profit : +71% (Turn every $1 into $1.71) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us

0 · Reply

RMN1 Dec. 31 at 7:51 PM

$TERN

0 · Reply

RMN1 Dec. 31 at 2:33 PM

$TERN - This years Last Opportunuty for SHORT or PUT.. Have party in new year!! Check this: https://www.insidermonkey.com/blog/jim-cramer-was-asked-about-these-11-stocks-1661888/2/

0 · Reply

TraderLawJCF Dec. 30 at 8:39 PM

$TERN Low volume manipulation on 98% institutional owned stock…scumbag MM

1 · Reply

RMN1 Dec. 30 at 5:48 PM

$TERN .. Check this.. it will come down soon.. to original price (less than 5 OR 10 ?? LOLOLOL) https://www.insidermonkey.com/blog/jim-cramer-was-asked-about-these-11-stocks-1661888/2/

0 · Reply

MoneyGroupLLC Dec. 29 at 3:49 PM

Enter: $TERN Calls Strike Price: $45 Expiry Date: FEB 20 2026 Buy in Price: $4.25 - $6.00 Sell Price: $9.39 Profit : +121% (Turn every $1 into $2.21) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us

0 · Reply

Market Cap	3.61B
Revenue (ttm)	0.00
Net Income (ttm)	-88.85M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	2,377,921
Avg Vol	4,534,138
Day's Range	N/A - N/A
Shares Out	90.08M
Stochastic %K	17%
Beta	-0.28
Analysts	Strong Sell
Price Target	$53.55